Kalidas Madhavpeddi V - 01 Mar 2023 Form 4 Insider Report for Trilogy Metals Inc. (TMQ)

Reporting relationship: Director
Issuer ticker: TMQ
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2023, 10:39:54 UTC
Prior SEC filing: 12 Dec 2022
Next SEC filing: 18 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Elaine Sanders as attorney-in-fact for Kalidas V. Madhavpeddi

Key filing fact

Kalidas Madhavpeddi V filed Form 4 for Trilogy Metals Inc. (TMQ) on 03 Mar 2023.

Key facts

This page summarizes Kalidas Madhavpeddi V's Form 4 filing for Trilogy Metals Inc. (TMQ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2023, 10:39.

Change

Previous filing in this sequence was filed on 12 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMQ transaction Derivative

Deferred Share Units

Award

Transaction value: $0
Shares: +24,524
Change %: +6.7%
Price: $0.000000
Shares after: 393,294
Date: 01 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,524
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Non-discretionary issuances of DSUs pursuant to elections made by plan participants prior to the commencement of the current fiscal year.

Footnote F2

The deferred share units vest immediately; however, the underlying common shares will not be issued to the grantee, and the grantee shall not have any voting or dispositive rights with respect to the underlying common shares, until termination of the grantee's employment or services as a director of the Issuer. The grants will expire no later than 90 days after the grantee's termination date.